文献速递慢性肾脏病

多基因评分与老年人慢性肾脏病表型的关联:一项纵向研究

Association of polygenic scores with chronic kidney disease phenotypes in a longitudinal study of older adults.
PubMed 文献 · Kidney Int · 2023-03-29

在澳大利亚ASPREE随机对照试验中,对11,813名70岁及以上、有基线eGFR的受试者进行基因分型,评估新近开发的CKD相关性状多基因评分(PGS)与基线eGFR、CKD临床表型及最长6年随访期间eGFR下降速率的关联。eGFR的PGS每增加1个标准差,基线eGFR显著降低3.9 mL/min/1.73m²(95%CI -4.17至-3.68);eGFR的PGS和CKD 3期的PGS均与基线CKD 3期风险升高相关;两个独立的eGFR斜率PGS与随访期间肾功能显著下降相关。

要点

  • eGFR的PGS每增加1个标准差,基线eGFR降低3.9 mL/min/1.73m²(95%CI -4.17至-3.68)。
  • eGFR的PGS与基线CKD 3期风险升高相关(OR 1.75每SD,95%CI 1.66-1.85)。
  • CKD 3期的PGS与基线CKD 3期风险升高相关(OR 1.51每SD,95%CI 1.43-1.59)。

核心结论

  • 在老年人中肾功能具有相当的遗传成分,肾脏疾病相关表型的新PGS可能对高龄CKD风险预测有潜在效用。

研究设计与样本

  • 研究基于澳大利亚ASPREE随机对照试验(每日低剂量阿司匹林)的纵向队列,纳入11,813名70岁及以上、有基线eGFR测量的基因分型健康老年人,随访最长6年。

主要发现

  • eGFR的PGS与基线eGFR相关,PGS每增加1个标准差,基线eGFR显著降低3.9 mL/min/1.73m²(95%CI -4.17至-3.68)。
  • 横断面分析中,eGFR的PGS与基线CKD 3期风险升高相关(OR 1.75每SD,95%CI 1.66-1.85)。
  • 横断面分析中,CKD 3期的PGS与基线CKD 3期风险升高相关(OR 1.51每SD,95%CI 1.43-1.59)。
  • 纵向分析中,两个独立的eGFR斜率PGS与随访期间肾功能显著下降相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Risk of chronic kidney disease (CKD) is influenced by environmental and genetic factors and increases sharply in individuals 70 years and older. Polygenic scores (PGS) for kidney disease-related traits have shown promise but require validation in well-characterized cohorts. Here, we assessed the performance of recently developed PGSs for CKD-related traits in a longitudinal cohort of healthy older individuals enrolled in the Australian ASPREE randomized controlled trial of daily low-dose aspirin with CKD risk at baseline and longitudinally. Among 11,813 genotyped participants aged 70 years or more with baseline eGFR measures, we tested associations between PGSs and measured eGFR at baseline, clinical phenotype of CKD, and longitudinal rate of eGFR decline spanning up to six years of follow-up per participant. A PGS for eGFR was associated with baseline eGFR, with a significant decrease of 3.9 mL/min/1.73m2 (95% confidence interval -4.17 to -3.68) per standard deviation (SD) increase of the PGS. This PGS, as well as a PGS for CKD stage 3 were both associated with higher risk of baseline CKD stage 3 in cross-sectional analysis (Odds Ratio 1.75 per SD, 95% confidence interval 1.66-1.85, and Odds Ratio 1.51 per SD, 95% confidence interval 1.43-1.59, respectively). Longitudinally, two separate PGSs for eGFR slope were associated with significant kidney function decline during follow-up. Thus, our study demonstrates that kidney function has a considerable genetic component in older adults, and that new PGSs for kidney disease-related phenotypes may have potential utility for CKD risk prediction in advanced age.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Bakshi A, Jefferis J, Wolfe R, et al. Association of polygenic scores with chronic kidney disease phenotypes in a longitudinal study of older adults. Kidney Int. 2023. PMID: 37001602. doi:10.1016/j.kint.2023.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。